BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Mylan Inc. 

1500 Corporate Drive

Canonsburg  Pennsylvania  15317  U.S.A.
Phone: 724-514-1800 Fax: n/a


SEARCH JOBS




Industry
Pharmaceutical






 Company News
Recent Signs Mylan (MYL) May be Gobbled Up by Teva (TEVA) 3/17/2015 6:37:11 AM
Mylan N.V. And Mylan Inc. (MYL) Announce Successful Completion Of Consent Solicitations For Mylan Inc.'s Notes 3/12/2015 10:55:23 AM
Mylan Inc. (MYL) Launches Generic Subutex Sublingual Tablets 3/11/2015 7:20:16 AM
Mylan Inc. (MYL) Launches Generic Antabuse Tablets 3/11/2015 7:03:32 AM
Mylan Inc. (MYL) Launches First And Only Available Intermediate Dosage Strengths Of Fentanyl Transdermal System 37.5, 62.5 And 87.5 Mcg/Hr 3/11/2015 7:01:03 AM
Mylan Inc. (MYL) To Present At The Barclays Global Healthcare Conference 3/6/2015 7:31:36 AM
Mylan N.V. And Mylan Inc. (MYL) Announce Commencement Of Consent Solicitations For Mylan Inc.'s Notes 3/3/2015 10:46:47 AM
Mylan Inc. (MYL) Files Annual Report On Form 10-K For Year Ended Dec. 31, 2014 3/3/2015 8:46:29 AM
Mylan Inc. (MYL) Fourth Quarter 2014 Adjusted Diluted EPS Increases 35% To $1.05 And Full Year Adjusted Diluted EPS Up 23% To $3.56 3/3/2015 7:57:27 AM
Mylan Inc. (MYL) Completes Acquisition Of Abbott (ABT)'s Non-U.S. Developed Markets Specialty And Branded Generics Business 2/27/2015 11:21:00 AM
12345678910...